中国医疗系统控股有限公司（股票代码：8A8）日前在新加坡交易所主板成功完成普通股二次上市。此次发行的每手交易单位为100股，标志着该集团在国际资本市场拓展取得关键突破。值得关注的是，公司主要上市地位仍保留于香港联合交易所主板，其股份继续维持在该市场的主要上市及交易状态。
此次跨境上市将强化企业在亚太资本市场的战略布局。通过搭建港股与新交所双重上市平台，公司不仅拓宽了国际投资者参与渠道，更有效提升了在东南亚金融枢纽的资本影响力。市场分析指出，这种双上市架构有助于优化股东结构，增强股票流动性，为未来区域业务扩张奠定资本基础。
此次上市采用直接挂牌模式，不涉及新股发行或资金募集。根据上市规则，新交所每手交易单位设定为100股，与香港市场交易机制形成互补。这种设计既符合当地投资者交易习惯，也便于国际资本进行跨市场套利操作。证券专家认为，差异化交易单元的设置彰显了公司对两地市场特性的精准把握。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.